|
|
 |
|
Viewing report
|
|
|
|
Consolidation / M&A in Medical Imaging Market
Frost & Sullivan, Dec 2009, Pages: 47
This Frost & Sullivan research service titled Consolidation/ M&A in Medical Imaging Market provides drivers for mergers and acquisitions (M&As), a timeline analysis and geographic analysis of acquisitions. This study offers a top-level picture of the various M&As in the medical imaging market in Europe, with a key focus on trends with respect to Tier I, II and III companies within the existing market.
Market Overview
M&A the Key for Market Leaders to Expand their Market Share in Emerging European Medical Imaging Markets
There has been a spur in the number of M&As in the European medical imaging market, with market leaders focussing on acquisitions to expand their share in emerging markets. Drug makers, research labs, equipment manufacturers and healthcare technology companies have been the active acquirers, whereas hospitals, insurers and pharmacological companies have a limited number of acquisitions. With healthcare industry being least affected by the economic downturn, there is sufficient funding available for healthcare deals, resulting in an increase in the number of takeovers. “The economic slump, availability of low-priced acquisitions, and ready-financing for the healthcare industry have increased the viability of tier I companies to expand market share through acquisitions,” says the analyst of this research. The focus of acquisition has been on emerging markets in countries such as Brazil, Russia, India, and China (BRIC), where M&A activity is likely to continue.
However, market expansion trends through acquisitions and strategic alliances indicate the entry of Japanese manufacturers in the US and European markets, whereas US companies have expanded their market share by acquiring smaller American companies. “Market expansion, technological developments, and competitive pricing will play an important role in the survival of non-tier I companies as tier I companies continue to enhance their position in all three criteria through strategic acquisitions,” explains the analyst.
The development of innovative technology and formation of strategic partnerships or alliances with influential market participants are the keys to success for most Tier II and Tier III companies in the medical imaging market. “Tier III companies will witness significant consolidation activity in the medical imaging market,” concludes the analyst. “Since the market is dominated by the tier I companies, tier III companies will be acquired for their technological developments and distribution channels, further increasing the domination of the tier I companies.”
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Electronic Medical Record Systems - Global Strategic Business Report
Dental Surgical Equipment - Global Strategic Business Report
Interventional Cardiology - Global Strategic Business Report
Medical Device Outsourcing - Global Strategic Business Report
Insulin Delivery Systems - Global Strategic Business Report
Advanced Wound Care Products - Global Strategic Business Report
Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio
Medical Imaging Equipment Services - Global Strategic Business Report
Mergers and Acquisitions in the Medical Device Industry
Brachytherapy - Global Strategic Business Report
|
|
|
|
